| Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers AP Sokolenko, EL Savonevich, AO Ivantsov, GA Raskin, ES Kuligina, ... Cancer letters 397, 127-132, 2017 | 51 | 2017 |
| The contribution of founder mutations in BRCA1 to breast cancer in Belarus N Uglanitsa, O Oszurek, K Uglanitsa, E Savonievich, J Lubiński, ... Clinical genetics 78 (4), 377-380, 2010 | 40 | 2010 |
| Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients AP Sokolenko, TN Sokolova, VI Ni, EV Preobrazhenskaya, AG Iyevleva, ... Breast Cancer Research and Treatment 184, 229-235, 2020 | 29 | 2020 |
| Molecular profiles of BRCA1‐associated ovarian cancer treated by platinum‐based therapy: Analysis of primary, residual and relapsed tumors AP Sokolenko, IV Bizin, EV Preobrazhenskaya, TV Gorodnova, ... International Journal of Cancer 146 (7), 1879-1888, 2020 | 24 | 2020 |
| BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update A Savanevich, O Ashuryk, C Cybulski, J Lubiński, J Gronwald Hereditary Cancer in Clinical Practice 19, 1-4, 2021 | 13 | 2021 |
| BRCA1 founder mutations compared to ovarian cancer in Belarus A Savanevich, O Oszurek, J Lubiński, C Cybulski, T Dębniak, SA Narod, ... Familial Cancer 13, 445-447, 2014 | 13 | 2014 |
| BRCA1 and BRCA2 genes mutations among women with clinical signs of hereditary breast cancer in western Belarus A Savanevich, M Vasilkevich, V Abdrashitov, T Stepuro Вестник Харьковского национального университета имени ВН Каразина. Серия …, 2021 | 2 | 2021 |
| Primary ovarian carcinomas arising in BRCA1 mutation carriers contain a small fraction of BRCA1-proficient cells, which rapidly repopulate tumor mass during neoadjuvant … E Imyanitov, A Sokolenko, T Gorodnova, E Savonevich, A Ivantsov, ... Annals of Oncology 30, v763, 2019 | 2 | 2019 |
| Loss of heterozygosity at the BRCA1 locus as a marker of sen-sitivity for adjuvant chemotherapy in hereditary ovarian cancer A Sokolenko, A Savanevich, T Stepuro, A Shulga, I Berlev, E Imyanitov, ... Biological Markers in Fundamental and Clinical Medicine 1 (3), 29-31, 2017 | 2 | 2017 |
| Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016 C Cybulski, W Kluźniak, T Huzarski, D Wokołorczyk, A Kashyap, ... Hereditary Cancer in Clinical Practice 15, 1-6, 2017 | 1 | 2017 |
| P128 Novel mechanism of acquired platinum resistance for BRCA1-driven malignancies: rapid expansion of pre-existing BRCA1-proficient tumor cells during neoadjuvant therapy for … E Imyanitov, I Berlev, T Gorodnova, E Savonevich, A Ivantsov, ... International Journal of Gynecologic Cancer 29 (Suppl 4), 2019 | | 2019 |
| Novel mechanism of platinum resistance: Rapid selection of pre-existing BRCA1-proficient tumor cells during neoadjuvant chemotherapy (NACT) for ovarian cancer (OC) in BRCA1 … E Imyanitov, E Savonevich, A Ivantsov, T Gorodnova, ... Annals of Oncology 29, vi4, 2018 | | 2018 |
| BRCA1 founder mutations and ovarian cancer in Belarus A Savanevich, A Ashuryk, J Lubinski, J Gronwald Hereditary Cancer in Clinical Practice 13, 1-1, 2015 | | 2015 |
